Matches in Wikidata for { <http://www.wikidata.org/entity/Q91686051> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q91686051 description "article scientifique publié en 2019" @default.
- Q91686051 description "artículu científicu espublizáu en xunu de 2019" @default.
- Q91686051 description "scientific article published on 13 June 2019" @default.
- Q91686051 description "wetenschappelijk artikel" @default.
- Q91686051 description "наукова стаття, опублікована 13 червня 2019" @default.
- Q91686051 name "Periprostatic Fat Thickness on MRI is an Independent Predictor of Time to Castration-resistant Prostate Cancer in Chinese Patients With Newly Diagnosed Prostate Cancer Treated With Androgen Deprivation Therapy" @default.
- Q91686051 name "Periprostatic Fat Thickness on MRI is an Independent Predictor of Time to Castration-resistant Prostate Cancer in Chinese Patients With Newly Diagnosed Prostate Cancer Treated With Androgen Deprivation Therapy" @default.
- Q91686051 type Item @default.
- Q91686051 label "Periprostatic Fat Thickness on MRI is an Independent Predictor of Time to Castration-resistant Prostate Cancer in Chinese Patients With Newly Diagnosed Prostate Cancer Treated With Androgen Deprivation Therapy" @default.
- Q91686051 label "Periprostatic Fat Thickness on MRI is an Independent Predictor of Time to Castration-resistant Prostate Cancer in Chinese Patients With Newly Diagnosed Prostate Cancer Treated With Androgen Deprivation Therapy" @default.
- Q91686051 prefLabel "Periprostatic Fat Thickness on MRI is an Independent Predictor of Time to Castration-resistant Prostate Cancer in Chinese Patients With Newly Diagnosed Prostate Cancer Treated With Androgen Deprivation Therapy" @default.
- Q91686051 prefLabel "Periprostatic Fat Thickness on MRI is an Independent Predictor of Time to Castration-resistant Prostate Cancer in Chinese Patients With Newly Diagnosed Prostate Cancer Treated With Androgen Deprivation Therapy" @default.
- Q91686051 P1433 Q91686051-CB84C816-B68C-402C-8911-9683500D6D1B @default.
- Q91686051 P1476 Q91686051-25C47FC5-E5DF-4C9D-8021-6EB7335358BB @default.
- Q91686051 P2093 Q91686051-16AB52B9-3BE6-4C46-9417-E12AD97629B2 @default.
- Q91686051 P2093 Q91686051-5BEA6F97-4839-42A2-936B-7E7B35170A98 @default.
- Q91686051 P2093 Q91686051-6701C0D9-01D9-4E0E-9EC3-E5A85D6F09E3 @default.
- Q91686051 P2093 Q91686051-780E8118-CD3C-4528-BEB0-F2838A75F9BE @default.
- Q91686051 P2093 Q91686051-866BC521-8F67-482C-837F-95F1DC1FA8A6 @default.
- Q91686051 P2093 Q91686051-DFCA263B-0FCC-4AD5-ACEA-853E18166BA2 @default.
- Q91686051 P304 Q91686051-5F02689D-CB84-4EEB-8AC0-40563164EA1F @default.
- Q91686051 P31 Q91686051-CD1A9EF9-ECC0-43DF-8339-8FC119D32A49 @default.
- Q91686051 P356 Q91686051-048CBFC1-EEDA-4E66-A48C-4E1BD4E43FAA @default.
- Q91686051 P433 Q91686051-6FAF49CB-6017-4776-AB63-FA6F66AE9C51 @default.
- Q91686051 P478 Q91686051-19A36F6D-E4CD-4EBF-BBB5-818801EC66CC @default.
- Q91686051 P577 Q91686051-939C071E-F082-4263-95EF-13A5EA7D61F6 @default.
- Q91686051 P698 Q91686051-6065301B-3A84-4B21-A5C4-E4425D59D0D1 @default.
- Q91686051 P921 Q91686051-03BE73D0-D279-473A-817D-905B640C5260 @default.
- Q91686051 P356 J.CLGC.2019.06.001 @default.
- Q91686051 P698 31281063 @default.
- Q91686051 P1433 Q332266 @default.
- Q91686051 P1476 "Periprostatic Fat Thickness on MRI is an Independent Predictor of Time to Castration-resistant Prostate Cancer in Chinese Patients With Newly Diagnosed Prostate Cancer Treated With Androgen Deprivation Therapy" @default.
- Q91686051 P2093 "Haichao Huang" @default.
- Q91686051 P2093 "Jinchun Xing" @default.
- Q91686051 P2093 "Peide Bai" @default.
- Q91686051 P2093 "Shi Chen" @default.
- Q91686051 P2093 "Wei Li" @default.
- Q91686051 P2093 "Xiurong Wu" @default.
- Q91686051 P304 "e1036-e1047" @default.
- Q91686051 P31 Q13442814 @default.
- Q91686051 P356 "10.1016/J.CLGC.2019.06.001" @default.
- Q91686051 P433 "5" @default.
- Q91686051 P478 "17" @default.
- Q91686051 P577 "2019-06-13T00:00:00Z" @default.
- Q91686051 P698 "31281063" @default.
- Q91686051 P921 Q181257 @default.